March 21st 2024
Office-based surgery could prove to be a viable option for physicians.
Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies
View More
(CME Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations
View More
(COPE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease
View More
(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease
View More
(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease
View More
(CME Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment
View More
(COPE Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment
View More
(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease
View More
18th Annual Controversies in Modern Eye Care
May 4, 2024
Register Now!
Headed to ARVO? You’re invited to dinner COPE CE/CME. Or join virtually!
May 6 & 7, 2024
Register Now!
(COPE Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations
View More
(CME Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
2nd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between
May 18-19, 2024
Register Now!
(COPE Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
(CME Credit) Virtual Case Studies™ in Cataract Surgery: Selecting Surgical Techniques and Preventing Intra-Operative Complications
View More
(COPE Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
Neurotrophic Keratitis Management: How Early Intervention Can Make a Difference
View More
(CME Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
17th Annual Controversies in Modern Eye Care
View More
Thyroid Eye Disease: The Masquerading Eye Disorder—A Guide to Collaborative Care and Accurate Diagnosis
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(COPE Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(COPE Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(CME Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
What’s New in MGD Beyond Heating and Squeezing?
View More
The Ins and Outs of Lubricating Eye Drops
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Expert Perspectives in Diabetic Macular Edema – Considering Pathogenesis & Inflammation in Treatment Selection
View More
Foldable iris-claw phakic IOL provides good visual outcomes
April 1st 2005Mainz, Germany—The first clinical results from the European Multicenter Trial of the Artiflex foldable iris-claw phakic IOL (Ophtec, Groningen, the Netherlands) indicated that the implant is safe and effective for treating myopia after a 6-month follow-up period.
Read More
Phakic IOL offers excellent outcomes for FDA cohort
March 15th 2005Atlanta—Up-to-date results from participants in the FDA clinical trial of the recently approved Verisyse phakic myopic IOL (Advanced Medical Optics) demonstrate that implant provides excellent refractive outcomes with a good safety profile, according to R. Doyle Stulting, MD, PhD.
Read More
Modified prolate anterior surface IOL improves acuity
March 15th 2005New Orleans—The modified prolate anterior surface IOL (Tecnis, AMO) is creating a new standard for visual performance after cataract surgery, according to Robert M. Kershner, MD, MS, FACS, at the Spotlight on Cataracts 2004: Cataract Controversies Symposium, held during the joint meeting of the American Academy of Ophthalmology and European Society of Ophthalmology.
Read More
Aspheric IOL brings benefits of being aberration-free
March 15th 2005Brookville, PA—The new aberration-free aspheric IOL (SofPort Advanced Optics, Bausch & Lomb) is an exciting advance in implant technology because of its potential to offer better quality of vision to all patients, said Louis D. "Skip" Nichamin, MD.
Read More
Disclose retina risks of of intraocular refractive surgery
March 15th 2005New Orleans—Patients undergoing intraocular refractive surgery with either refractive lens exchange (RLE) or phakic intraocular lens implantation need to be informed that there is a lifelong risk of retinal detachment, said Kirk H. Packo, MD, at the refractive surgery subspecialty day at the American Academy of Ophthalmology annual meeting.
Read More
Late-onset bleb leakage needs immediate attention
February 15th 2005New Orleans—Late-onset bleb leakage needs to be controlled to avoid such complications as blebitis or bleb-related endophthalmitis, which can result in poor visual outcome, reported Philip P. Chen, MD, during the glaucoma subspecialty day meeting at the American Academy of Ophthalmology annual meeting.
Read More
Cyclophotocoagulation helpful for refractory glaucoma
February 15th 2005New Orleans—Patients with refractory glaucoma may be candidates for transscleral or endoscopic cyclophotocoagulation (CPC) to lower IOP (Figure 1), although there is no direct evidence comparing the two approaches, explained Neeru Gupta, MD, PhD.
Read More
How to rescue failing blebs successfully
February 1st 2005New Orleans—Bleb needling may be a good approach for early bleb failure if medication, digital massage, and suture lysis or removal are not effective. In the case of late bleb failure, YAG laser lysis of the sclerotomy, bleb needling, and bleb revision are favored, according to glaucoma specialist Jon M. Ruderman, MD.
Read More
Improvements seen with laser photolysis system
January 15th 2005Nuremberg, Germany—The latest refinements in the Dodick laser photolysis system (A.R.C. Laser GmbH)—a new handpiece design, shorter pulse laser, and power VAC tubing system and improved laser hardware—have resulted in what investigators believe is a procedure that is superior to conventional ultrasound phacoemulsification.
Read More
Allergan cuts jobs in Ireland as AMO assumes operations
December 15th 2004Dublin, Ireland-Allergan Inc. will cut more than 300 jobs this spring at its Westport plant in western Ireland as it transfers its contact lens solutions operations there to Advanced Medical Optics Inc. (AMO) of Santa Clara, CA.
Read More
Implant benefits non-infectious posterior segment uveitis
November 15th 2004Baltimore-Intraocular implantation of fluocinolone acetonide (Retisert, Bausch & Lomb) has resulted in significant decreases in the recurrence rate of non-infectious posterior segment uveitis and improvements in visual acuity (VA), it was an-nounced at the annual meeting of the Retina Society here.
Read More
Anterior chamber IOLs have evolved over time
November 15th 2004There are many locations within the eye that an IOL can be placed. Most often, lenses are placed in the bag, but they may be placed in the sulcus, sewn into the posterior chamber, or sewn into or clipped onto the iris. Another location can be in the anterior chamber. Let's look at the evolution of anterior chamber IOLs (AC IOLs) in this month's column.
Read More
Aqueous misdirection is complication of intraocular surgery
November 1st 2004New York-Aqueous misdirection is "a rare, but serious complication of intraocular surgery" that requires immediate attention to prevent lasting damage, Celso Tello, MD, told participants at the Glaucoma 2004 meeting here.
Read More
Dermis fat graft: neglected in management of socket problems?
October 24th 2004Dermis fat grafts have become "overlooked" as orbital implants in favor of newer alternatives but deserve to maintain a role in primary and secondary socket implant procedures, and more complex socket problems, said James A. Katowitz, MD, Children's Hospital of Philadelphia.
Read More
Another approach for presbyopia on the horizon
October 23rd 2004NuLens Ltd., a company formed 2 years ago in Herzliya Pituach, Israel, has developed a new accommodative IOL technology that offers more than 10 D of accommodative power, according to Joshua Ben-Nun, MD, chief scientific officer, NuLens, who spoke at a breakfast session during the American Academy of Ophthalmology annual meeting.
Read More
Late onset bleb leakage should be managed carefully
October 23rd 2004Late onset bleb leakage usually occurs 2 to 3 years after glaucoma filtering surgery with an incidence between 2% and 9%. This condition warrants treatment, according to Philip P. Chen, MD, who spoke during the glaucoma subspecialty day meeting.
Read More
12-month results positive for laser presbyopia reversal
October 22nd 2004Laser presbyopia reversal (LAPR) is showing significant promise and patient satisfaction based on 12-month follow-up results from a U.S. clinical trial, said Sandra C. Belmont, MD, at the refractive surgery subspecialty day meeting.
Read More
12-month results positive for laser presbyopia reversal
October 22nd 2004Laser presbyopia reversal (LAPR) is showing significant promise and patient satisfaction based on 12-month follow-up results from a U.S. clinical trial, said Sandra C. Belmont, MD, at the refractive surgery subspecialty day meeting.
Read More
Botulinum toxin improves blepharospasm symptoms
October 15th 2004S?o Paulo, Brazil-Botulinum toxin type A (Botox, Allergan) significantly improves all aspects of quality of life in patients with blepharospasm, according to Tammy Osaki, MS, a medical student at the Vision Institute of the Federal University of S?o Paulo, Brazil.
Read More
No need to dissect conjunctiva during posterior vitrectomy
October 15th 2004San Diego-A system for performing a sutureless posterior vitrectomy uses 25-gauge cannula instruments that can be inserted directly through the conjunctiva and eliminates the need for its dissection. The transconjunctival sutureless vitrectomy system (TSV25, Bausch & Lomb) reduces the problems associated with performing surgery in eyes with a shallow anterior chamber, according to Rosa Braga-Mele, MD.
Read More
Radial scleral ablation trial promising for presbyopia
October 1st 2004San Diego-Scleral ablation with the 2.94 erbium:YAG laser for the treatment of presbyopia seems to be an effective and safe procedure in most patients, according to Bobby Maddox, MD, here at the American Society of Cataract and Refractive Surgery annual meeting.
Read More